GSK Investigational Site

Haverhill, Massachusetts 1830

0 studies enrolling now · 13 studies all time

What they study most

Atherosclerosis, Diabetes Mellitus, Type 2, Hypertension, Neoplasms, Prostate

Studies at this site

• Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early
• A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes — Completed
• Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes — Completed
• Safety and Efficacy Study of Albiglutide in Type 2 Diabetes — Completed
• Safety and Efficacy of Albiglutide in Type 2 Diabetes — Completed
• Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only — Completed
• An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin — Completed
• Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension — Completed